BioSpace News Archive

ROTH Capital Partners (“ROTH”), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that Yasmeen Rahimi, Ph.D., Managing Director and Senior Research Analyst, has been promoted to the role of Co-Head of Biotechnology Research.

Aquila, a leader in on-site fitness & well-being management services announced positive financial results for the year ended December 31, 2018.

More than 600 leaders of the New York financial industries raised nearly $720,000 for National Jewish Health, the nation’s number one respiratory hospital, and honored Tom Greco, CEO of Hilco Valuation & Industries Services, at the 2019 Financial Industries Dinner on March 14

TITLE Boxing Club, the nation’s leading boutique boxing fitness franchise with more than 190 clubs open across the United States, announced today it has sold the franchise rights for all of Manhattan to Michael Tosto, current multi-unit franchisee

Located at the newly-inaugurated King’s College Hospital London in Dubai Hills

Allouche has over 20 years of combined experience in finance leadership, audit, and advisory roles, most recently serving as Principal Accounting Officer, Head of Finance, and Corporate Controller at Revance Therapeutics

BTL, leaders in non-invasive aesthetics, today announced that eight studies have been accepted for presentation at the 39th Annual Conference of the American Society for Laser Medicine & Surgery (ASLMS) taking place March 27th – 31st.

Dr. Reddy’s Laboratories Ltd. announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Cialis (tadalafil) Tablets in the United States market, approved by the U.S. Food and Drug Administration (USFDA).

Enanta Pharmaceuticals, Inc. announced that new preclinical data from Enanta’s wholly-owned development programs for hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH) have been accepted for presentations at The International Liver Congress™ (ILC) 2019, April 10-14, in Vienna, Austria.

Centene Corporation and WellCare Health Plans, Inc. announced that Centene will acquire WellCare in a cash and stock transaction for $305.39 per share based on Centene’s closing stock price on March 26, 2019 for a total enterprise value of $17.3 billion pursuant to the terms of a definitive merger agreement.